Suppr超能文献

帕金森病中多巴胺能功能与动机的双向相关性。

Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease.

机构信息

Medical Scientist Training Program, 1500Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Department of Neurology, 1500Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

J Geriatr Psychiatry Neurol. 2022 May;35(3):353-362. doi: 10.1177/0891988721996802. Epub 2021 Feb 24.

Abstract

OBJECTIVE

To test the hypothesis that striatal dopamine function influences motivational alterations in Parkinson disease (PD), we compared vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DaT) imaging data in PD patients with impulse control disorders (ICDs), apathy, or neither.

METHODS

We extracted striatal binding ratios (SBR) from VMAT2 PET imaging (F-AV133) and DaTscans from the Parkinson's Progression Markers Initiative (PPMI) multicenter observational study. Apathy and ICDs were assessed using the Movement Disorders Society-revised Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP), respectively. We used analysis of variance (ANOVA) and log-linear mixed-effects (LME) regression to model SBRs with neurobehavioral metrics.

RESULTS

Among 23 participants (mean age 62.7 years, mean disease duration 1.8 years) with VMAT2 imaging data, 5 had apathy, 5 had an ICD, and 13 had neither. ANOVA indicated strong groupwise differences in VMAT2 binding in right anterior putamen [F(2,20) = 16.2, p < 0.0001), right posterior putamen [F(2,20) = 16.9, p < 0.0001), and right caudate [F(2,20) = 6.8, p = 0.006)]. Post-hoc tests and repeated-measures analysis with LME regression also supported right striatal VMAT2 elevation in the ICD group and reduction in the apathy group relative to the group with neither ICD nor apathy. DaT did not exhibit similar correlations, but normalizing VMAT2 with DaT SBR strengthened bidirectional correlations with ICD (high VMAT2/DaT) and apathy (low VMAT2/DaT) in all striatal regions bilaterally.

CONCLUSIONS

Our findings constitute preliminary evidence that striatal presynaptic dopaminergic function helps describe the neurobiological basis of motivational dysregulation in PD, from high in ICDs to low in apathy.

摘要

目的

为了验证纹状体多巴胺功能是否会影响帕金森病(PD)患者的动机改变这一假说,我们对比了伴有冲动控制障碍(ICD)、淡漠或两者皆无的 PD 患者的囊泡单胺转运体 2(VMAT2)和多巴胺转运体(DaT)成像数据。

方法

我们从帕金森进展标志物倡议(PPMI)多中心观察性研究中的 VMAT2 PET 成像(F-AV133)和 DaT 扫描中提取纹状体结合比(SBR)。使用运动障碍协会修订的统一帕金森病评定量表(MDS-UPDRS)和帕金森病冲动-强迫问卷(QUIP)分别评估淡漠和 ICD。我们使用方差分析(ANOVA)和对数线性混合效应(LME)回归来对 SBR 与神经行为学指标进行建模。

结果

在 23 名接受 VMAT2 成像数据的参与者(平均年龄 62.7 岁,平均病程 1.8 年)中,5 名患有淡漠,5 名患有 ICD,13 名两者皆无。ANOVA 表明,右侧前壳核[F(2,20) = 16.2,p < 0.0001]、右侧后壳核[F(2,20) = 16.9,p < 0.0001]和右侧尾状核[F(2,20) = 6.8,p = 0.006]的 VMAT2 结合存在强烈的组间差异。事后检验和 LME 回归的重复测量分析也支持 ICD 组右侧纹状体 VMAT2 升高,淡漠组 VMAT2 降低,与既无 ICD 也无淡漠的组相比。DaT 则没有表现出类似的相关性,但将 VMAT2 与 DaT SBR 进行归一化,可增强双侧所有纹状体区域与 ICD(高 VMAT2/DaT)和淡漠(低 VMAT2/DaT)之间的双向相关性。

结论

我们的发现初步证明了纹状体前突触多巴胺功能有助于描述 PD 中动机失调的神经生物学基础,从 ICD 中的高到淡漠中的低。

相似文献

1
Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease.
J Geriatr Psychiatry Neurol. 2022 May;35(3):353-362. doi: 10.1177/0891988721996802. Epub 2021 Feb 24.
3
Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2065-2076. doi: 10.1007/s00259-019-04396-3. Epub 2019 Jul 4.
4
Longitudinal decline in striatal dopamine transporter binding in Parkinson's disease: associations with apathy and anhedonia.
J Neurol Neurosurg Psychiatry. 2023 Oct;94(10):863-870. doi: 10.1136/jnnp-2022-330790. Epub 2023 May 23.
5
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
Lancet Neurol. 2017 May;16(5):351-359. doi: 10.1016/S1474-4422(17)30056-X. Epub 2017 Mar 20.
6
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
Parkinsonism Relat Disord. 2015 May;21(5):489-93. doi: 10.1016/j.parkreldis.2015.02.015. Epub 2015 Feb 25.
7
Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.
J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):864-70. doi: 10.1136/jnnp-2015-311827. Epub 2015 Nov 3.
9
Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
Parkinsonism Relat Disord. 2019 Jul;64:235-241. doi: 10.1016/j.parkreldis.2019.04.006. Epub 2019 Apr 16.

引用本文的文献

2
Serotonergic dysfunction in patients with impulse control disorders in Parkinson's disease.
Brain. 2025 Jun 3;148(6):2108-2121. doi: 10.1093/brain/awaf087.
3
Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism.
Neural Regen Res. 2025 Jan 1;20(1):93-106. doi: 10.4103/1673-5374.391180. Epub 2023 Dec 21.
4
Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease.
Front Neurol. 2021 Nov 5;12:733570. doi: 10.3389/fneur.2021.733570. eCollection 2021.

本文引用的文献

1
Co-occurrence of apathy and impulse control disorders in Parkinson disease.
Neurology. 2020 Nov 17;95(20):e2769-e2780. doi: 10.1212/WNL.0000000000010965. Epub 2020 Oct 1.
2
CLME: An R Package for Linear Mixed Effects Models under Inequality Constraints.
J Stat Softw. 2016;75. doi: 10.18637/jss.v075.i01. Epub 2016 Nov 19.
4
Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline.
Neurology. 2020 Jan 28;94(4):e376-e383. doi: 10.1212/WNL.0000000000008683. Epub 2019 Nov 15.
5
Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity.
Neurology. 2019 Aug 13;93(7):e675-e687. doi: 10.1212/WNL.0000000000007942. Epub 2019 Jul 16.
7
Parkinson disease.
Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13.
8
ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):317-324. doi: 10.1136/jnnp-2016-315277.
9
Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.
Eur J Neurosci. 2017 Jan;45(1):20-33. doi: 10.1111/ejn.13357. Epub 2016 Sep 2.
10
Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.
J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):864-70. doi: 10.1136/jnnp-2015-311827. Epub 2015 Nov 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验